Dr Ameya Puranik

Even for current generation of T20 players it’s the Test greats who are the mentors and ‘goto’ persons; salute to RSD, Dada, VVS and SRT; just goes to show it’s the basics that matter; whatever maybe the format of the sport. #fab4 #T20WorldChampion

Good to see TARE move up the ladder

Final print of BCLC 2025 available at authors.elsevier.com/c/1mZTWcOnAYVAl A team effort by BCLC members and external experts. Incorporation of CUSE concepts into the MTBoard allows personalised recommendations @hospitalclinic @idibaps @EASLnews @ILCAnews @AEEHLiver @ContraCancerEs

Tb-161 DOTATATE PRRT was given to patients refractory to Lu177 PRRT. Having treated more than 8 patients at @TataMemorial and @ACTREC_TMC, ours is one of the leading centres for Terbium therapy. @Indraja28_11 @DrVAChaudhari @Manishbhandare4 @AnantRamaswamy @VikasO

Honoured to deliver an Invited Talk at the Theranostics World Congress 2026, Cape Town 🇿🇦, on ‘Terbium-161 DOTATATE in Neuroendocrine Tumors’, highlighting its theranostic promise, radiobiological advantages, and role in next-generation targeted radionuclide therapy. #TWC2026

@AmanChauhanMD Thanks ..Won’t be attending ENETS though.

@docameya Ameya hope alls well. See ya at ENETS and all the best with the study

Thanks @AmanChauhanMD for sharing the pics.. nice to see our PReCedeNT trial featuring in one of the slides

A masterclass on the evolution of radioligand therapy in NETs and its future directions, delivered brilliantly by the fantastic @helops79 #NRG2026 @huntsmancancer

आधी एक crisis तयार करायचा..तो चिघळू द्यायचा…आणि जनतेने सगळ्या यातना भोगल्यानंतर crisis handle करायचा..आणि ‘good governance’ चा काढा घोटून घोटून लोकांच्या गळी उतरवायचा ..@girishkuber उत्कृष्ट लेख..गरज आहे अशी निर्भीड शाब्दिक चपराक द्यायची

The study is nearing completion of recruitment with a sample size of 162. Grateful to NET Clinic @TataMemorial for supporting this study @Shrikhande_SV @DrVAChaudhari @Manishbhandare4 @Indraja28_11 @AnantRamaswamy @VikasOstwal10

Excited to share that PRECEDENT trial protocol is now published in BMc Cancer @BMC_series This prospective study compares PRRT alone vs PRRT + CAPE-TEM in FDG-avid, well-differentiated metastatic neuroendocrine tumors . rdcu.be/eNclJ

Are you like I, struggling with sequencing systemic therapies in G2/G3 GEPNETs and wondering where PRRT fits in that picture...? If so, you might find this paper helpful. Sure, we need better data but here is what we know. @AmanChauhanMD @NVijayvergiaMD mdpi.com/2072-6694/17/1…

This photo is so heart warming! Divya Deshmukh arrives in Nagpur after winning the FIDE Women's World Cup 2025 and is greeted by hundreds of people! She then held the photo frame of her first coach Rahul Joshi and dedicated her GM title to him. Rahul, a wonderful chess trainer, passed away at the tender age of just 40 years. Speaking about her first trainer Divya said, "He always wanted me to be a GM. I dedicate my GM title to him!" Divya's beautiful gesture reminds us to always remember our roots! Photo: Tushar Damor #chess #chessbaseindia #divyadeshmukh

“We collect books because they are our anchors in a sea of change.” — Russell Lynes

Surprised that the organizers of @isnr_2025, didn't find a single Nuclear Medicine Physician in city of Bengaluru or elsewhere to deliver talk on PET imaging in gliomas and PET tracers; shocking is that they invited a radiologist and a physicist; reasons best known to them.

Do you want to know what is happening in radioligand therapy for patients with neuroendocrine tumors? What is hot and what is not...? if so, @docameya @Indraja28_11 and Vikas Prasad have you covered... 😀 onlinelibrary.wiley.com/doi/10.1111/jn…

@OncoThor @Indraja28_11 Thanks so much Thor..

लहानपणी क्रिकेटचे वेड आणि त्यातील विश्लेषणाची आणि आकड्यांची आवड केवळ या एका व्यक्तीमुळे निर्माण झाली... भावपूर्ण श्रद्धांजली संझगिरी काका..🙏

Do your treat low grade M1 GEP-NETs aggresively? Our experience @TataMemorial @docameya @Shrikhande_SV link.springer.com/10.1007/s12029…